Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
boston blog main
3
×
boston top stories
clinical trials
life sciences
national blog main
480 biomedical
ally bridge group
arsenal medical
big data analytics
blackrock
bob langer
cancer
casdin capital
chronic rhinosinusitis
codiak biosciences
covid-19
cutaneous t-cell lymphoma
deals
diabetic nephropathy
drug delivery
eventide asset management
exosome
fda
focal segmental glomerulosclerosis
genzyme
george whitesides
goldfinch bio
inflammation
investing
ipo
irving investors
jay ghosh
jazz pharmaceuticals
keros therapeutics
lyra therapeutics
medical device
mometasone furorate
national top stories
What
ipo
million
3
×
new
3
×
biotech
company
medicines
raised
raises
tests
analysis
based
begin
bio
biosciences
bio’s
bring
brings
bubbles
cells
class
clinical
codiak
debut
develop
developing
diseases
drug
employing
exosome
exosomes
formed
fund
genetic
goldfinch
kidney
late
later
lead
lyra
markets
Language
unset
3
×
Current search:
unset
×
million
×
new
×
" boston blog main "
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses